1. FIB-4 index-based surveillance for advanced liver fibrosis in diabetes patients
- Author
-
Hirokazu Takahashi, Hiroshi Isoda, Nozomi Kawata, Kenichi Tanaka, Shinji Iwane, Yuichiro Eguchi, Hitoe Mori, Kanako Inoue, Motoyasu Kojima, Yoshiaki Egashira, Keizo Anzai, Yayoi Matsuda, Jyunichi Nojiri, Hiroyuki Irie, Satoshi Oeda, and Michiko Kohno
- Subjects
medicine.medical_specialty ,Cirrhosis ,business.industry ,Endocrinology, Diabetes and Metabolism ,Liver fibrosis ,Fatty liver ,030209 endocrinology & metabolism ,030204 cardiovascular system & hematology ,Fib 4 index ,medicine.disease ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Diabetes mellitus ,Hepatocellular carcinoma ,Internal Medicine ,Medicine ,Original Article ,Prediabetes ,business ,Liver cancer - Abstract
Liver fibrosis is associated with lifestyle-related diseases, including diabetes. The identification of diabetic patients with severe liver fibrosis is important, but a simple and reliable diagnostic procedure remains to be determined. We conducted an observational study to evaluate the performance of a FIB-4 index-based screening strategy for the diagnosis of advanced liver fibrosis in patients with diabetes or prediabetes. Two hundred and forty-two patients underwent abdominal imaging in our Study. According to the abdominal imaging findings, fatty liver, liver cirrhosis, and hepatocellular carcinoma were defined, and their association with FIB-4 index evaluated. The prevalences of liver cirrhosis and hepatocellular carcinoma in patients with a high (≥ 2.67; liver cirrhosis: 42.9%, hepatocellular carcinoma: 14.3%) FIB-4 index were significantly higher than in those with an intermediate (1.3 ≤ FIB-4
- Published
- 2020
- Full Text
- View/download PDF